Torthaí cuardaigh - Giorgio Fasolini
- 1 - 4 toradh as 4 á dtaispeáint
-
1
Reducing Polycystic Liver Volume in ADPKD de réir Anna Caroli, Luca Antiga, Mariateresa Cafaro, Giorgio Fasolini, Andrea Remuzzi, Giuseppe Remuzzi, Piero Ruggenenti
Foilsithe / Cruthaithe 2010Artigo -
2
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease de réir Piero Ruggenenti, Andrea Remuzzi, Patrizia Ondei, Giorgio Fasolini, Luca Antiga, Bogdan Ene‐Iordache, Giuseppe Remuzzi, Franklin H. Epstein
Foilsithe / Cruthaithe 2005Artigo -
3
Sirolimus Therapy to Halt the Progression of ADPKD de réir Norberto Perico, Luca Antiga, Anna Caroli, Piero Ruggenenti, Giorgio Fasolini, Mariateresa Cafaro, Patrizia Ondei, Nadia Rubis, Olimpia Diadei, Giulia Gherardi, Silvia Prandini, Andrea Panozo, Rodolfo Flores Bravo, Sergio Carminati, Felipe Rodríguez De León, Flavio Gaspari, Monica Cortinovis, Nicola Motterlini, Bogdan Ene‐Iordache, Andrea Remuzzi, Giuseppe Remuzzi
Foilsithe / Cruthaithe 2010Artigo -
4
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4 de réir Piero Ruggenenti, Giorgio Gentile, Norberto Perico, Annalisa Perna, Luca Barcella, Matias Trillini, Monica Cortinovis, Claudia Patricia Ferrer Siles, Jorge Arturo Reyes Loaeza, M Aparicio, Giorgio Fasolini, Flavio Gaspari, Davide Martinetti, Fabiola Carrara, Nadia Rubis, Silvia Prandini, Anna Caroli, Kanishka Sharma, Luca Antiga, Andrea Remuzzi, Giuseppe Remuzzi
Foilsithe / Cruthaithe 2016Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Autosomal dominant polycystic kidney disease
Gastroenterology
Kidney
Kidney disease
Urology
Alternative medicine
Endocrinology
Pathology
Placebo
Renal function
Sirolimus
Somatostatin
Albuminuria
Cancer research
Concomitant
Crossover study
Octreotide
Polycystic kidney disease
Prospective cohort study
Proteinuria
Randomization
Randomized controlled trial